openPR Logo
Press release

Pregabalin Market to Register High Demand Rate Worldwide: Top Manufactures, Challenges And Drivers By 2025 And Key Players Are Lupin, Cipla, Genesis Remedies, Sanofi, Biomax

03-27-2019 03:22 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Pregabalin Market

Pregabalin Market

Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.

Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. According to the Global Year Against Neuropathic Pain 2014-2015 report by International Association of the Study of Pain, around 7%8% of adults suffer from chronic pain with neuropathic characteristics. Furthermore, Pfizers patent expiry of Lyrica (Pregabalin) in 2018 is anticipated to increase the market share of generic manufacturing companies in the UK.

Download Request Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2652

However, stringent government regulations, lack of awareness about neuropathic pain, presence of substitutes of Pregabalin such as gabapentin, and adverse drug effects hinder the market growth. High investment in developing nations are proving new opportunities for the market players.

The Pregabalin market is segmented on the basis of application, end user, and geography. Based on application, the market is divided into epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Based on the end user, it is classified into research institutes, pharmaceutical companies, and others (hospitals and clinics). Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits
• The study provides an in-depth analysis of the global Pregabalin market, with current trends and future estimations to elucidate the investment pockets.
• Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
• The report presents a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of different segments facilitates to understand various products of the market.
• Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

List of players profiled in the report

• Pfizer Inc.
• Torrent Pharmaceuticals Ltd.
• Lupin Limited
• Zydus Cadila Healthcare Ltd.
• Cipla Limited
• Genesis Remedies
• Sanofi
• Medley Pharmaceuticals Limited
• Genesis Biotec Inc.
• Biomax

Send Enquiry Us @ https://www.alliedmarketresearch.com/purchase-enquiry/2652

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pregabalin Market to Register High Demand Rate Worldwide: Top Manufactures, Challenges And Drivers By 2025 And Key Players Are Lupin, Cipla, Genesis Remedies, Sanofi, Biomax here

News-ID: 1673219 • Views: 230

More Releases from Allied Market Research

Orthopedic Prosthetics Market Will Expand in the Coming Decade
Orthopedic Prosthetics Market report analyses the prospects in the market for several shareholders and aspirants by identifying the high-growth segments, main actions approved by them and Orthopedic Prosthetics market recent progressions. The Orthopedic Prosthetics market report is prepared after fundamental levels of research regarding the Orthopedic Prosthetics Industry. Orthopedic Prosthetics Market by Product (Upper Extremity Prosthetics, Lower Extremity Prosthetics, Liners, Sockets, and Modular Components) Technology (Conventional, Electric Powered, and Hybrid
Orthopedic Operating Tables Market Challenges and New Trends
According to a new report published by Allied Market Research, titled, ” Orthopedic Operating Tables Market by Technology (Non-powered Operating Tables and Powered Operating Tables) and End Users (Hospitals and Ambulatory Surgical Centers (ASCs)) – Global Opportunity and Forecast, 2019-2026”. The Global market size of Orthopedic Operating Tables market is $XX million in 2018 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with
Orthopedic Consumables Market Analysis of The Current and Emerging Trends
According to a new report published by Allied Market Research, titled, ” Orthopedic Consumables Market by Product (Surgical Orthopedic Consumables, Wound-Management Orthopedic Consumables, and Others) and End Users (Hospitals, Clinics, Ambulatory Surgical Centers (ASCs), and Others) – Global Opportunity and Forecast, 2019-2026 The Global market size of Orthopedic Consumables market is $XX million in 2018 with XX CAGR, and it is expected to reach $XX million by the end of 2027
Intraosseous Infusion Device Market Challenges and New Trends
According to a new report published by Allied Market Research, titled, “Intraosseous Infusion Device Market by Product Type (FAST1 device, Dieckmann Modified Needle, BIG device, EZ-IO device, Jamshidi Needle, FASTx device, and NIO), by Technology (Battery Powered Driver, Manual IO Needles, and Impact Driven Devices), by Route of Administration (Distal Femur, Sternum, Distal & Proximal Tibia, Calcaneus, and Head of Humerus), by End User (Hospitals, Emergency Medical Services, Ambulatory Surgical

All 5 Releases


More Releases for Pregabalin

Global Pregabalin market:Potential Segments & their Contribution to Market Size …
The global Pregabalin market is exhaustively researched and analyzed in the report to help market players to improve their business tactics and ensure long-term success. The authors of the report have used easy-to-understand language and uncomplicated statistical images but provided thorough information and detailed data on the global Pregabalin market. The report equips players with useful information and suggests result-oriented ideas to gain a competitive edge in the global Pregabalin
Pregabalin Market Demand, Production Growth, Top Key Players and Forecast to 202 …
The report elaborates the complete details covering product definition, product type, and application. The report covers useful details which are categorized based on Pregabalin production region, major players, and product type which will provide a simplified view of the Pregabalin industry. The Pregabalin market report presents the competitive scenario of the major market players based on the sales revenue, customer demands, company profile, the business tactics used in Pregabalin market
Huge Investment in Pregabalin Market Expected to Witness the Highest Growth 2024 …
The growing demand for Pregabalin has provided a major boost to the Global Pregabalin Market as more people are shifting their preferences to this growing sector. The market is expected to keep rising at a high CAGR and reach values of high millions by the end of the forecast period of 2020 up to 2024. Overview of Global Pregabalin Market: Pregabalin, marketed under the brand name Lyrica among others, is a medication
Pregabalin Market 2020 | Increasing Demand With Leading Key Players Pfizer Inc., …
According to a new report published by Allied Market Research, titled, "Pregabalin Market by Application (Epilepsy, Neuropathic Pain, Fibromyalgia, and Generalized Anxiety Disorder) and End User (Research Institutes, Pharmaceutical Companies, and Others) - Global Opportunity Analysis and Industry Forecast, 2020-2027". The global market size of Pregabalin market is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR
Pregabalin Market Witnessing a Robust Growth With Impressive CAGR During Forecas …
Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves a decrease in pain signals sent by the damaged nerves in the body. Increase in a geriatric population suffering from neuropathic diabetes and the rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. Download Sample Report @
Pregabalin Market in-depth analysis with current trends and future estimations 2 …
Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body. Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. According to the Global Year against Neuropathic